As of May 27
| +0.60 / +2.95%|
The 8 analysts offering 12-month price forecasts for AMAG Pharmaceuticals Inc have a median target of 41.00, with a high estimate of 80.00 and a low estimate of 27.00. The median estimate represents a +95.61% increase from the last price of 20.96.
The current consensus among 9 polled investment analysts is to Buy stock in AMAG Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.